![](/img/cover-not-exists.png)
338 A pilot trial of thymalfasin (Thymosin alpha-1) in combination with peginterferon alpha-2A (PEG-IFN2A) and ribavirin in HCV non-responders: 12-week interim results
Jorge L. Poo, Xochil Garcia, Eduardo B. Martins, David KershanobichVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80381-6
File:
PDF, 153 KB
english, 2003